TRIB
Trinity Biotech plc
NASDAQ: TRIB · HEALTHCARE · MEDICAL DEVICES
$0.59
-4.26% today
Updated 2026-06-03
Market cap
$13.77M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-2.00
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
Trinity Biotech plc (TRIB) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.59
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$3.19
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -85.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.